178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Osteoarthritis biomarker could help cut $23 billion health bill

Osteoarthritis biomarker could help cut $23 billion health bill

by Candy Gibson,University of South AustraliaCredit: Pixabay/CC0 Public DomainUniversity of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful

Osteoarthritis biomarker could help cut $23 billion health bill

by Candy Gibson,University of South AustraliaCredit: Pixabay/CC0 Public DomainUniversity of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful
What's behind the new advice to stop taking glucosamine for arthritis?

What's behind the new advice to stop taking glucosamine for arthritis?

by Nial Wheate and Joanna Harnett,The ConversationCredit: AI-generated imageThe Australian Rheumatology Associationthis week warnedpeople not to take the supplement glucosamine for t

What's behind the new advice to stop taking glucosamine for arthritis?

by Nial Wheate and Joanna Harnett,The ConversationCredit: AI-generated imageThe Australian Rheumatology Associationthis week warnedpeople not to take the supplement glucosamine for t
Study identifies key protein that drives rheumatoid arthritis damage

Study identifies key protein that drives rheumatoid arthritis damage

by Judith Van Dongen,Washington State UniversityCredit: Unsplash/CC0 Public DomainScientists have identified a protein known as sulfatase-2 that plays a critical role in the damage caused by rhe

Study identifies key protein that drives rheumatoid arthritis damage

by Judith Van Dongen,Washington State UniversityCredit: Unsplash/CC0 Public DomainScientists have identified a protein known as sulfatase-2 that plays a critical role in the damage caused by rhe
Parents scrambling after asthma inhaler Flovent removed from market

Parents scrambling after asthma inhaler Flovent removed from market

by Dennis ThompsonA popular asthma inhaler was discontinued on Jan. 1, and the business move has left families scrambling to find a replacement for their kids.Flovent was one of the most commonly pres

Parents scrambling after asthma inhaler Flovent removed from market

by Dennis ThompsonA popular asthma inhaler was discontinued on Jan. 1, and the business move has left families scrambling to find a replacement for their kids.Flovent was one of the most commonly pres
The double face of RNase as a treatment for systemic autoimmune diseases

The double face of RNase as a treatment for systemic autoimmune diseases

by Osaka UniversityThe RNA-degrading enzyme enhances the function of immune complexes formed by autoantibodies against Ro/SSA and La/SSB antigens. Credit: Ryota Naito et al. JCI Insight 2023Syste

The double face of RNase as a treatment for systemic autoimmune diseases

by Osaka UniversityThe RNA-degrading enzyme enhances the function of immune complexes formed by autoantibodies against Ro/SSA and La/SSB antigens. Credit: Ryota Naito et al. JCI Insight 2023Syste
Non-surgical treatment quickly reduces arthritis knee pain and improves function

Non-surgical treatment quickly reduces arthritis knee pain and improves function

by Society of Interventional RadiologyCredit: CC0 Public DomainA non-surgical treatment for arthritis in the knee is safe and effective in providing immediate and long-term pain relief, according

Non-surgical treatment quickly reduces arthritis knee pain and improves function

by Society of Interventional RadiologyCredit: CC0 Public DomainA non-surgical treatment for arthritis in the knee is safe and effective in providing immediate and long-term pain relief, according
VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages
Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these
Study examines the course of back pain over time

Study examines the course of back pain over time

by WileyCredit: CC0 Public DomainBack pain is among the most frequently reported health problems in the world. New research published inArthritis Care & Research, an official journal of

Study examines the course of back pain over time

by WileyCredit: CC0 Public DomainBack pain is among the most frequently reported health problems in the world. New research published inArthritis Care & Research, an official journal of
COVID-19 immunity may last six months or more

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t

COVID-19 immunity may last six months or more

by Meghan Rosen,Howard Hughes Medical InstituteScientists found traces of SARS-CoV-2 (green) in cells lining people’s intestines three months after infection. Antibodies may evolve in response t
Scientists solve 18-year-old mystery and find the once-elusive source of a critical T cell population

Scientists solve 18-year-old mystery and find the once-elusive source of a critical T cell population

by Delthia Ricks , Medical XpressPresence of Tcf7+CD8+T cells during the primary response to infection. (A) Experimental schematic: Naïve P14 cells (CD45.2) were transferred into congenica

Scientists solve 18-year-old mystery and find the once-elusive source of a critical T cell population

by Delthia Ricks , Medical XpressPresence of Tcf7+CD8+T cells during the primary response to infection. (A) Experimental schematic: Naïve P14 cells (CD45.2) were transferred into congenica